zinterol has been researched along with Airflow Obstruction, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AD; Bunnage, ME; Burrows, JL; Clarke, NP; Feeder, N; Glossop, PA; James, K; Jones, RM; Lane, CA; Lewthwaite, RA; Perros-Huguet, C; Price, DA; Spence, FJ; Taylor, SC; Trevethick, MA; Webster, R; Yeadon, M | 1 |
1 other study(ies) available for zinterol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Asthma; Benzeneacetamides; Bronchoconstriction; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Dogs; Female; Guinea Pigs; Hepatocytes; Humans; In Vitro Techniques; Liver; Male; Microsomes, Liver; Models, Molecular; Molecular Structure; Muscle, Smooth; Pulmonary Disease, Chronic Obstructive; Rats; Stereoisomerism; Sulfonamides; Trachea | 2010 |